AR and prostate carcinoma: Although the potential mechanism by which VNPP433-3β facilitates AR degradation is not completely clear, a recent study has provided evidence that VNPP433-3β serves as a molecular glue that effectively degrades AR and AR-V7, thereby inhibiting oncogenic signaling pathways in prostate cancer cells [165].